Transnasal Humidified Rapid Insufflation Ventilatory Exchange With Nasopharyngeal Airway Facilitates Apneic Oxygenation: A Randomized Clinical Noninferiority Trial

Lingke Chen, Liu Yang, Weitian Tian, Xiao Zhang, Yanhua Zhao, Lili Huang, Jie Tian, Jiaqiang Zhang, Jiangxia Wu, Weifeng Yu, Diansan Su, Lingke Chen, Liu Yang, Weitian Tian, Xiao Zhang, Yanhua Zhao, Lili Huang, Jie Tian, Jiaqiang Zhang, Jiangxia Wu, Weifeng Yu, Diansan Su

Abstract

Background: Transnasal humidified rapid insufflation ventilatory exchange (THRIVE) was used to extend the safe apnea time. However, THRIVE is only effective in patients with airway opening. Nasopharyngeal airway (NPA) is a simple device that can help to keep airway opening. This study aimed to investigate the noninferiority of NPA to jaw thrust for airway opening during anesthesia-induced apnea. Methods: This was a prospective randomized single-blinded noninferiority clinical trial on the use of THRIVE in patients with anesthesia-induced apnea. The participants were randomly allocated to receive NPA or jaw thrust. The primary outcomes were PaO2 and PaCO2 at 20 min after apnea, with noninferiority margin criteria of -6.67 and 0.67 kPa, respectively. Results: A total of 123 patients completed the trial: 61 in the NPA group and 62 in the jaw thrust group. PaO2 at 20 min after apnea was 42.9 ± 14.0 kPa in the NPA group and 42.7 ± 13.6 kPa in the jaw thrust group. The difference between these two means was 0.25 kPa (95% CI, -3.87 to 4.37 kPa). Since the lower boundary of the 95% CI was > -6.67 kPa, noninferiority was established because higher PO2 is better. PaCO2 at 20 min after apnea was 10.74 ± 1.09 kPa in the NPA group and 10.54 ± 1.18 kPa in the jaw thrust group. The difference between the two means was 0.19 kPa (95% CI, -0.14 to 0.53 kPa). Since the upper boundary of the 95% CI was <0.67 kPa, noninferiority was established because lower PCO2 is better. No patient had a SpO2 < 90% during apnea. Conclusion: When THRIVE was applied during anesthesia-induced apnea, NPA placement kept airway opening and was noninferior to jaw thrust in terms of its effects on PaO2 and PaCO2 at 20 min after apnea. Clinical Trial Registration: ClinicalTrials.gov (NCT03741998).

Keywords: THRIVE; apneic oxygenation; arterial blood gas; general anesthesia; nasopharyngeal airway.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2020 Chen, Yang, Tian, Zhang, Zhao, Huang, Tian, Zhang, Wu, Yu and Su.

Figures

Figure 1
Figure 1
The NPA group and jaw thrust group received OptiflowTM THRIVE system (Fisher & Paykel Healthcare, Auckland, New Zealand). (A) Humidifiers and heating system. (B) Flow meter. (C) Heated and humidified inspiratory circuit. (D) NPA. (E) Transnasal oxygen cannula. NPA, nasopharyngeal airway; THRIVE, transnasal humidified rapid insufflation ventilatory exchange.
Figure 2
Figure 2
The CONSORT flow diagram.
Figure 3
Figure 3
Nasopharyngeal airway facilitates transnasal humidified rapid insufflation ventilatory exchange and is noninferior to jaw thrust. (A) For PaO2, the difference value between the two groups was 0.25 kPa, and the 95% confidence interval was −3.87 to 4.37 kPa. Since the lower boundary of the confidence interval was > −6.67 kPa, noninferiority could be established because higher PO2 is better. (B) For PCO2, the difference value between the two groups was 0.19 kPa, and the 95% confidence interval was −0.14 to 0.53 kPa. Since the upper limit of the confidence interval was <0.67 kPa, noninferiority was established because lower PCO2 is better.
Figure 4
Figure 4
Arterial blood gases of the nasopharyngeal airway and jaw thrust groups during transnasal humidified rapid insufflation ventilatory exchange. There are no significant differences in PaO2(A), PaCO2(B), pH (C), standard base excess (D), and HCO3−(E) between the two groups. (F) For the nasopharyngeal airway group, the line represents linear regression with r = 0.8324 and p < 0.0001. The regression equation was Y = 2.123 *X + 40.30. For the jaw thrust group, the line represents linear regression with r = 0.7999 and p < 0.0001. The regression equation was Y = 2.054 *X + 40.68. MV, mechanical ventilation.
Figure 5
Figure 5
Vital signs of the nasopharyngeal airway (NPA) and jaw thrust groups during transnasal humidified rapid insufflation ventilatory exchange. (A) In all patients, the SpO2 at 20 min after apnea is >90%. (B,C) There are no significant differences between the two groups for the SpO2 and mean arterial pressure (MAP) at each time point. (D) At 20 min after apnea and 10 min after intubation, the heart rate (HR) is higher in the NPA group than in the jaw thrust group. There are no significant differences between the two groups at the other time points. MV, mechanical ventilation.

References

    1. Patel A, Nouraei SA. Transnasal humidified rapid-insufflation ventilatory exchange (THRIVE): a physiological method of increasing apnoea time in patients with difficult airways. Anaesthesia. (2015) 70:323–9. 10.1111/anae.12923
    1. Gustafsson IM, Lodenius A, Tunelli J, Ullman J, Jonsson Fagerlund M. Apnoeic oxygenation in adults under general anaesthesia using transnasal humidified rapid-insufflation ventilatory exchange (THRIVE) - a physiological study. Br J Anaesth. (2017) 118:610–7. 10.1093/bja/aex036
    1. Badiger S, John M, Fearnley RA, Ahmad I. Optimizing oxygenation and intubation conditions during awake fibre-optic intubation using a high-flow nasal oxygen-delivery system. Br J Anaesth. (2015) 115:629–32. 10.1093/bja/aev262
    1. Miguel-Montanes R, Hajage D, Messika J, Bertrand F, Gaudry S, Rafat C, et al. . Use of high-flow nasal cannula oxygen therapy to prevent desaturation during tracheal intubation of intensive care patients with mild-to-moderate hypoxemia. Crit Care Med. (2015) 43:574–83. 10.1097/CCM.0000000000000743
    1. Sakles JC, Mosier JM, Patanwala AE, Dicken JM. Apneic oxygenation is associated with a reduction in the incidence of hypoxemia during the RSI of patients with intracranial hemorrhage in the emergency department. Intern Emerg Med. (2016) 11:983–92. 10.1007/s11739-016-1396-8
    1. McNarry AF, Patel A. The evolution of airway management - new concepts and conflicts with traditional practice. Br J Anaesth. (2017) 119:i154–66. 10.1093/bja/aex385
    1. Renda T, Corrado A, Iskandar G, Pelaia G, Abdalla K, Navalesi P. High-flow nasal oxygen therapy in intensive care and anaesthesia. Br J Anaesth. (2018) 120:18–27. 10.1016/j.bja.2017.11.010
    1. Huang L, Dharmawardana N, Badenoch A, Ooi EH. A review of the use of transnasal humidified rapid insufflation ventilatory exchange for patients undergoing surgery in the shared airway setting. J Anesth. (2020) 34:134–43. 10.1007/s00540-019-02697-3
    1. Damrose EJ, Manson L, Nekhendzy V, Collins J, Campbell R. Management of subglottic stenosis in pregnancy using advanced apnoeic ventilatory techniques. J Laryngol Otol. (2019) 133:399–403. 10.1017/S0022215119000690
    1. Benninger MS, Zhang ES, Chen B, Tierney WS, Abdelmalak B, Bryson PC. Utility of transnasal humidified rapid insufflation ventilatory exchange for microlaryngeal surgery. Laryngoscope. (2020) 10.1002/lary.28776. [Epub ahead of print].
    1. To K, Harding F, Scott M, et al. . The use of transnasal humidified rapid-insufflation ventilatory exchange in 17 cases of subglottic stenosis. Clin Otolaryngol. (2017) 42:1407–10. 10.1111/coa.12921
    1. Ueshima H, Goda T, Otake H. Transnasal humidified rapid-insufflation ventilatory exchange can be utilized in tracheal stenosis caused by thyroid tumor. J Clin Anesth. (2020) 62:109727. 10.1016/j.jclinane.2020.109727
    1. Sorbello M, Mir F, McNarry AF. THRIVE? The answer, my friend, is blowing in the (high flow) wind! Trends Anaesth Crit Care (2018) 22:63–5. 10.1016/j.tacc.2018.08.006
    1. Piaggio G, Elbourne DR, Pocock SJ, Evans SJ, Altman DG, CONSORT Group Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. JAMA. (2012) 308:2594–604. 10.1001/jama.2012.87802
    1. Bourn S, Milligan P, McNarry AF. Use of transnasal humidified rapid-insufflation ventilatory exchange (THRIVE) to facilitate the management of subglottic stenosis in pregnancy. Int J Obstet Anesth. (2020) 41:108–13. 10.1016/j.ijoa.2019.07.004
    1. Stock MC, Schisler JQ, McSweeney TD. The PaCO2 rate of rise in anesthetized patients with airway obstruction. J Clin Anesth. (1989) 1:328–32. 10.1016/0952-8180(89)90070-6
    1. Vernon DD, Witte MK. Effect of neuromuscular blockade on oxygen consumption and energy expenditure in sedated, mechanically ventilated children. Crit Care Med. (2000) 28:1569–71. 10.1097/00003246-200005000-00051
    1. Lin Y, Zhang X, Li L, Wei M, Zhao B, Wang X, et al. . High-flow nasal cannula oxygen therapy and hypoxia during gastroscopy with propofol sedation: a randomized multicenter clinical trial. Gastrointest Endosc. (2019) 90:591–601. 10.1016/j.gie.2019.06.033
    1. Mir F, Patel A, Iqbal R, Cecconi M, Nouraei SA. A randomised controlled trial comparing transnasal humidified rapid insufflation ventilatory exchange (THRIVE) pre-oxygenation with facemask pre-oxygenation in patients undergoing rapid sequence induction of anaesthesia. Anaesthesia. (2017) 72:439–43. 10.1111/anae.13799
    1. Xu T, Li M, Ni C, Guo XY. Dexmedetomidine vs. remifentanil for sedation during awake intubation using a Shikani optical stylet: a randomized, double-blinded, controlled trial. BMC Anesthesiol. (2016) 16:52 10.1186/s12871-016-0219-9
    1. Shen SL, Xie YH, Wang WY, Hu SF, Zhang YL. Comparison of dexmedetomidine and sufentanil for conscious sedation in patients undergoing awake fibreoptic nasotracheal intubation: a prospective, randomised and controlled clinical trial. Clin Respir J. (2014) 8:100–7. 10.1111/crj.12045
    1. Jeung HJ, Kwak SH, Ri M, Jeong CW, Kim SJ, Bae HB. Effect of mixed administration of propofol and rocuronium on intubating conditions. Korean J Anesthesiol. (2009) 56:140–5. 10.4097/kjae.2009.56.2.140
    1. Md Shahnawaz M, Shahjahan B, Sarwar SS. Evaluation of intubating conditions after rocuronium bromide in adults induced with propofol or thiopentone sodium. J Anaesthesiol Clin Pharmacol. (2011) 27:215–9. 10.4103/0970-9185.81829

Source: PubMed

3
Abonnere